Neurocognitive Outcome of Childhood ALL Survivors Using Three Different Protocols Over a Decade

Blood ◽  
2011 ◽  
Vol 118 (21) ◽  
pp. 4226-4226
Author(s):  
Mohsen Saleh Elalfy ◽  
Iman Ahmed Ragab ◽  
Enas Ahmed Azab ◽  
Shaimaa Nasr ◽  
Marwa Abdel Maguid
Keyword(s):  
Frontal Cortex ◽  
Diffusion Tensor ◽  
Treated Group ◽  
Control Group ◽  
High Dose ◽  
Cognitive Tests ◽  
Neurocognitive Dysfunction ◽  
Childhood All ◽  
Significant Difference ◽  
And Control

Abstract Abstract 4226 Patients with childhood ALL achieve long-term disease-free survival, making reducing complications of therapy of major concerns. The aim of this study was to assess the prevalence and degree of neurocognitive dysfunction in survivors of childhood ALL treated with different protocols and the effect of time since end of chemotherapy. Patients and methods: A cross-sectional study including 60 ALL survivors aged 5–16 years at enrollment; 2–9 years at diagnosis, CNS1, treated through 1998–2008 and regularly followed up in childhood cancer survivors clinic;. They were compared to 20 healthy age and sex matched controls. Grade of school, scholastic achievement in the previous year were reported followed by revision of hospital records including type and risk of ALL, protocol of treatment, number, type and dose of intrathecal chemotherapy, number and doses of high dose I.V methotrexate, data of cranial radiotherapy. Three different protocols were applied to these patients according to the time of diagnosis, patients diagnosed between January 1998 to December 2000 were treated with Modified BFM 83. Those diagnosed between January 2001 to June2004 were treated with BFM 90 protocol, and those diagnosed From July 2004 to June 2008 were treated with CCG 1991 for standard risk and CCG 1961 for high risk patients.Neurocognitive functions were tested using Wechsler Intelligence Scale for Children,Benton visual retention (BVR) test and Trail making test (part A and B were done. MRI Brain was performed to the patients and control group using diffusion weighed images and diffusion tensor magnetic resonance imaging (DTI). Results: Survivors treated with CCG protocol showed a significant decrease in all cognitive tests results compared to control (p<0.05). Survivors treated with BFM 90 protocol had a significant lower total IQ, verbal IQ, TMT-partA, compared to both control and survivors treated with Modified BFM 83, and a significant decrease in performance IQ, BVRT and TMT-partB compared to control only. No significant difference between results of cognitive tests in survivors treated with Modified BFM 83 and control group. Both left and right frontal cortex apparent diffusion coefficient (ADC) was significantly higher in CCG(.88±.060.91±.028) treated group compared to control(.695±.0018.684±.0018), BFM 90(.79±.071.76±.048) and modified BFM 83(.76±.030.83±.023×10&minus;3mm2/s) groups (p<0.05) yet a significant decrease in FA of right frontal cortex only in CCG (.250±.039)treated group compared to control(.684±.0018), BFM 90(.450±.042) and Modified BFM 83(.41±.028) groups(p<0.05). FA of right frontal, was significantly lower in BFM 90 and Modified BFM 83 treated group compared to control group. No significant correlation was found between cognitive tests results with age at diagnosis, time since the end of therapy, total number of intrathecal injections, age at radiotherapy treatment, dose and time of radiotherapy. Cognitive tests didn’t differ between survivors treated with triple intrathecal therapy(ITTT) compared to those treated with intrathecal methotrexate, yet significant decrease in FA of right hippocampus in survivors who received ITTT compared to survivors treated with intrathecal monotherapy, Conclusion: Neurocognitive dysfunction was a common sequelae of childhood ALL treatment. It was more related to protocol of therapy rather than the duration of follow-up since end of chemotherapy. Frontal lobe FA may be a clinically useful biomarker for the assessment of neurotoxicity in post-treatment childhood ALL survivors. Disclosures: No relevant conflicts of interest to declare.

scholarly journals Enhanced intestinal 2-deoxy-2-[18F]fluoro-D-glucose uptake under metformin is not fully suppressed by loperamide

2018 ◽  
Vol 52 (4) ◽  
pp. 185-191
Author(s):  
Tomomi Nobashi ◽  
Tsuneo Saga ◽  
Yuji Nakamoto ◽  
Yoichi Shimizu ◽  
Sho Koyasu ◽  
...  
Keyword(s):  
Body Weight ◽  
Small Intestine ◽  
Low Dose ◽  
Control Group ◽  
High Dose ◽  
Fdg Uptake ◽  
Significant Difference ◽  
Mouse Small Intestine ◽  
Long Acting ◽  
And Control

AbstractObjective. This study investigated whether the metformin (Met)-induced enhanced intestinal uptake of 2-deoxy-2-[18F]fluoro-D-glucose (18F-FDG) is reduced by loperamide, a long-acting anti-diarrheal agent. Methods. Mean18F-FDG uptake in the mouse small intestine and colon with Met exposure was compared with that in control mice. In the Met group, high-dose (1.0 mg/kg body weight) and low-dose (0.1 mg/kg body weight) loperamide were introduced, and18F-FDG uptake in the small intestine and colon was compared with that of control mice administered high-dose loperamide. The percent injected dose of18F-FDG per gram of tissue (%ID/g) in the extracted tissues was then determined. Results.18F-FDG uptake increased significantly in the small intestine (0.64±0.06 vs. 1.01±0.15, p=0.040) and, especially, the colon (0.46±0.13 vs. 2.16±0.51, p<0.001) after Met exposure. Neither high-dose nor low-dose loperamide significantly reduced18F-FDG uptake in the small intestine (0.82±0.31 vs. 0.84±0.22, p=0.93 and 0.78±0.25 vs. 0.70±0.15, p=0.13, respectively) or colon (2.13±0.41 vs. 1.67±0.55, p=0.063 and 1.77±0.39 vs. 1.80±0.25, p=0.56, respectively). The colonic %ID/g was significantly higher in Met groups irrespective of loperamide introduction than in control group, whereas the significant difference in the small intestine was observed only between Met and control groups. Conclusion. Metformin increased18F-FDG uptake in intestines especially in colon. Loperamide administration partially, but not sufficiently, suppresses the Met-induced increased colonic uptake of18F-FDG.

A study model with initial findings using Sepia 200c given prophylactically to prevent anoestrus problems in the dairy cow

1990 ◽  
Vol 78 (03) ◽  
pp. 132-134 ◽  
Author(s):  
A.V. Williamson ◽  
W.J. Crawford ◽  
B. Rennie ◽  
W.L. Mackie
Keyword(s):  
Dairy Cows ◽  
Reproductive Performance ◽  
Dairy Cow ◽  
Treated Group ◽  
Lower Proportion ◽  
Control Group ◽  
Service Period ◽  
Significant Difference ◽  
Index 2 ◽  
And Control

AbstractOverall reproductive performance and associated periparturient disorders were monitored in a herd of British Friesian cross dairy cows from September 1987 to August 1988. Pregnancy diagnosis and cyclical status of the herd was determined by palpation of the ovaries per rectum. A total of 49 (110) cows were randomly treated with Sepia 200c either on day 14(19) or 21 days (30) postpartum.Statistical analysis of the results was based on the differences between the control and combined Sepia-treated groups. Although there were significant differences in the proportion of heifers calving in each group, there was no significant difference in periparturient disorders or during the pre-service period.However, in the Sepia Group that held a lower proportion of heifers, a significant difference was found in the conception rate to 1st service (47%), the percentage of cows in calf (90%) and total culling rate (10%) compared to the Control Group (26%, 72% and 28% respectively). A reduction (non significant) was found between the Sepia and Control services to conception (0.2), calving to conception interval (5 days) and calving index (2 days).The results of this pilot study appear to demonstrate a difference in effect between the Sepia-treated Group and Control Group. The study has been extended to treat a larger number of dairy cows to examine the reproducibility of these results.

scholarly journals Comparative evaluation of electrocardiographic effects of different doses of medetomidine and xylazine in calf-camels (Camelus dromedarius)

2020 ◽  
Vol 23 (1) ◽  
pp. 89-101 ◽  
Author(s):  
A. Samimi ◽  
E. Sakhaee ◽  
F. Iranmanesh
Keyword(s):  
Cardiac Arrhythmia ◽  
Comparative Evaluation ◽  
P Wave ◽  
Control Group ◽  
High Dose ◽  
Interval Duration ◽  
Rr Interval ◽  
Significant Difference ◽  
And Control ◽  
Different Doses

This experimental, prospective, randomised, and blinded study aimed to perform comparative evaluation of electrocardiographic (ECG) effects of different doses xylazine and medetomidine in dromedary calves after intravenous (IV) administration. A total of twenty five clinically and paraclinically healthy male dromedary calves aged 15±2 weeks and weighing 95±5.5 kg were assigned randomly to five different groups (four experimental and one control). Groups XL and XH received a low (0.2 mg kg-1) and high (0.4 mg kg-1) dose of xylazine hydrochloride and groups ML and MH received a low (10 µg kg-1) and high (20 µg kg-1) dose of medetomidine hydrochloride once, IV. Finally, the control group (C) received normal saline in the same manner. ECG indices were evaluated on post treatment 0, 5, 10, 15, 30, 60, 90, 120 min, and 24 h. There was no significant difference in heart rate (HR) in all experimental groups at T90. HR was significantly lower after high doses than after low doses of medetomidine and xylazine at T120. HR was significantly lower in XH than in other groups of study at T24. At T90 QRS amplitude in XH was statistically lower than in control and XL groups. Analysis of P wave duration revealed that in MH and XH it was significantly longer than in ML, XL and control at T5. Duration of P wave in control group was significantly shorter than in all experimental groups from T10 to T90. RR interval duration was significantly shorter at T5 and T10 in control group compared to experimental groups. At T120, RR interval duration in MH and XH was considerably longer than that in ML, XL, and control. Compared with control group, cardiac arrhythmia scores were significantly lower than in all experimental groups from T5 to T60. At T90 and T120 in MH and XH, cardiac arrhythmia scores were significantly higher than those of XL, ML, and control. According to our findings, using low dose of medetomidine (10 µg kg-1) and xylazine (0.2 mg kg-1) was suggested in comparison with high dose of medetomidine (20 µg kg-1) and xylazine (0.4 mg kg-1) in dromedary calves with cardiac diseases in the field.

scholarly journals INVESTIGATION ON THE COUNTERACTING EFFECT OF SPIRULINA AGAINST POTENTATED SULFONAMIDE’S (COTRIM DS®) SIDE EFFECTS IN RAT

2013 ◽  
Vol 10 (1-2) ◽  
pp. 81-86 ◽  
Author(s):  
M. K. Islam ◽  
S. Akter ◽  
S. Bala ◽  
M. Z. Hossain ◽  
M.S. Akter
Keyword(s):  
Hematological Parameters ◽  
Experimental Period ◽  
Treated Group ◽  
Control Group ◽  
High Dose ◽  
Spirulina Maxima ◽  
Liver And Kidney ◽  
Group A ◽  
Group B ◽  
And Control

An experiment was conducted to investigate the counteracting effects of spirulina in Long Evans rats exposed to oral potentiated sulfonamide administration. 20 rats were randomly assigned into four equal groups (A, B, C and D) and were fed with standard broiler pellet (25g/rat/day) throughout the experimental period of 60 days. Rats of Group A were fed only with pellet without any experimental diet and were defined as control. Rats  of Group B were treated with potentiated sulfonamide @ 96 mg/rat/day orally whereas Group C was treated with potentiated sulfonamide @ 96 mg/rat/day plus spirulina (Spirulina maxima) @ 50 mg/rat/day orally (low dose spirulina). In Group D, potentiated sulfonamide and spirulina (Spirulina maxima) were given through feed @ 96 mg/rat/day and @ 100 mg/rat/day (high dose spirulina) respectively. Hematological parameters (TEC, Hb and absolute count of lymphocyte, neutrophil and eosinophil) and hispathological profile of liver and kidney were recorded. The investigation revealed that the oral administration of sulfonamide significantly (p<0.01) decreased the TEC (5.93±0.24) value, number of lymphocyte (581.76±3.70) and neutrophil (581.76±3.70) compared to other treated groups and control group. On the other hand significant (p<0.01) increase (422.86±2.34) in eosinophil population has been found in rats fed on sulfonamide irrespective of spirulina supplementation on the final day of experiment compared to other treated group and control group. From this experiment it is evidenced that spirulina has a potential counteracting effect against sulfonamide. Histopathology of kidney and liver was done at the end of experiment (60 days) and no significant change was found except in the kidney of Group B and C.DOI: http://dx.doi.org/10.3329/bjvm.v10i1-2.15650

scholarly journals Effect of Polarized Light Treatment on Milk Production and Milk Somatic Cell Count of Cows

2008 ◽  
Vol 77 (2) ◽  
pp. 225-229 ◽  
Author(s):  
M. Fenyő ◽  
G. Szita ◽  
J. Bartyik ◽  
J. Dóra ◽  
S. Bernáth
Keyword(s):  
Somatic Cell ◽  
Milk Yield ◽  
Polarized Light ◽  
Treated Group ◽  
Control Group ◽  
Cell Counts ◽  
Significant Difference ◽  
Linearly Polarized ◽  
The Mean ◽  
And Control

Treatment with linearly polarized light (LPL) is a widely used and recognized therapeutic method in human medicine for healing wounds, ulcers and a variety of other dermatological problems. Polarized light mobilizes the inadequately functioning defence mechanisms of the human body. The aim of the present experiment was to investigate the effect of LPL treatment on the udder of milking cows. Before the start of treatment, there was no significant difference between cows to be treated with LPL and the control cows in mean somatic cell counts (SCC) of milk samples taken separately by udder quarter and in the mean milk yield. The LPL treatment lasted for 20 min and was performed twice a day over a period of one month. Before treatment, the mean SCC of milk was 3.47 × 105 ± 910 in the group to be treated and 4.07 × 105 ± 920 in the control group. In a six-week period immediately after treatment, the mean SCC of the treated and the control group was 1.32 × 105 ± 825 and 2.63 × 105 ± 825, indicating a significant difference in favour of the treated group. Before the LPL treatment, the milk yield of cows in the group to be treated was 25.77 ± 1.2 kg/ day, while that of the control cows was 27.30 ± 1.4 kg/day. In a six-week period after treatment, the milk yield of cows in the treated and control groups was 28.83 ± 1.5 kg/day and 25.48 ± 1.4 kg/day, respectively. There is a significant difference between these values in favour of the treated group. The results show that a regular LPL treatment of the udder of cows can significantly reduce the SCC of milk and significantly increase the milk yield. The treatment can be applied during lactation without interfering with the milking regime.

scholarly journals The effect of red wine extract, resveratrol, on the degree and rate of orthodontic tooth movement in guinea pigs

2015 ◽  
Vol 5 ◽  
pp. 181-189
Author(s):  
Isidro Alex C. Urriquia ◽  
Lotus D. Llavore
Keyword(s):  
Guinea Pigs ◽  
Low Dose ◽  
Tooth Movement ◽  
Orthodontic Tooth Movement ◽  
Control Group ◽  
High Dose ◽  
Male Adult ◽  
Significant Difference ◽  
The Mean ◽  
And Control

ObjectiveAn animal trial, its protocol approved by the Institutional Animal Care and Use Committee of the U.P. National Institutes of Health (IACUC Protocol No. 2010-008), was employed to investigate the effects of resveratrol on the degree and rate of orthodontic tooth movement in guinea pigs.Materials and MethodsEighteen male adult guinea pigs were randomly allocated into 3 groups: low dose, high dose, and control groups. A 0.016″ titanium molybdenum alloy wire formed into a helical torsion spring with a coil, with the loops cemented onto the maxillary incisors of the animals, served as the orthodontic appliance. Daily oral administration of resveratrol was provided to the low dose (0.047 mg/kg) and high dose (0.47 mg/kg) groups, while water was provided to the control group. Measurements were taken everyday at the interproximal area at the level of the incisal edge using a measuring caliper.ResultsThe results of the ANOVA showed no statistically significant differences in the mean measurements of tooth separation among the three groups from day 2 (P=0.966) to day 8 (P=0.056). However, starting from day 9 (P=0.049) until day 18 (P=0.000), there was a significant difference in the mean tooth separation among the test groups.ConclusionUsing the LSD, it was noted that the low dose and the high dose groups have similar degrees of mean tooth separation, with the control group being significantly different from the two.

Study of Walnut Oil Supplementation on Serum Biochemical Parameters and Histopathology of Male Rats

2021 ◽  
Vol 19 (6) ◽  
pp. 08-14
Author(s):  
Mohammed Zuheir Hassan ◽  
Mohammed Jaffer AL- Anssari ◽  
Hayder Hasan Rajab ◽  
Ali Abbas Abo Ajon ◽  
Ashraf Raoof Mohammed Ali ◽  
...  
Keyword(s):  
Lipid Profile ◽  
Total Protein ◽  
Histological Study ◽  
Treated Group ◽  
Male Rats ◽  
Whole Body ◽  
Control Group ◽  
Walnut Oil ◽  
Significant Difference ◽  
And Control

The purpose of the experiment is an investigate the association of walnut oil with lipid profiles, glucose as well as total proteins and assessment its side effect on some sensitive organs such as the liver and spleen tissues. The experiment divided into two main groups are treated group with walnut oil and the control group, where the former divided into two subgroups 0.25 and 0.5 ml of oil per each. We found a statistically non-significant difference between treated and control groups (for total protein, lipid profile, and glucose). There was no change in total protein, but cholesterol decreased by 0.25 ml but a little increased by 0.5 ml. HDL was increased for the treated group. While on 0.25 ml LDL decreased in treated animals, on another hand no change for 0.5 ml. Also, no change for VLDL between treated and control. The only triglyceride was increased but non-significant for the treated group compared with the control. Both doses decreased in treated animals for glucose. We also found an increase in whole-body weight and on sensitive organs such as the liver and spleen. Even no change in a histological study for the mentioned organs. The conclusion: By walnut oil, all parameters have changed despite the treated group was normal without any induced diseases. So, recommended the researchers induce the disorders in the liver and assessment the extracted oil on the lipid profile.

scholarly journals An Investigation Into the Beneficial Effects of High-Dose Interferon beta 1-a, Compared to Low-Dose Interferon Beta 1-a (the base therapeutic regimen) in moderate to severe COVID-19

2021 ◽  
Author(s):  
Ilad Alavi Darazam ◽  
Firouze Hatami ◽  
Mohammad Mahdi Rabiei ◽  
Mohamad Amin Pourhoseingholi ◽  
Minoosh Shabani ◽  
...  
Keyword(s):  
Low Dose ◽  
Interferon Beta ◽  
Intervention Group ◽  
Control Group ◽  
High Dose ◽  
Research Committee ◽  
Subcutaneous Injections ◽  
Beneficial Effects ◽  
Significant Difference ◽  
And Control

Abstract Introduction: Coronavirus disease 2019 (COVID-19) has been a serious obstacle in front of public health. Interferon-beta 1a (IFN-β 1a) has been used to treat patients with COVID-19. We aimed to compare the effectiveness of high-dose IFN-β 1a compared to low dose IFN-β 1a in moderate to severe COVID-19 cases.Methods: In this randomized, controlled, and clinical trial, eligible patients with confirmed SARS-CoV-2 infections were randomly assigned to receive one of the two following therapeutic regimens: The intervention group was treated with high-dose IFN-β 1a (Recigen) (Subcutaneous injections of 88μg (24,000 IU) on days 1, 3, 6) + lopinavir /ritonavir (Kaletra) and the control group was treated with low-dose IFN-β 1a (Recigen) (Subcutaneous injections of 44μg (12,000 IU) on days 1, 3, 6) + lopinavir /ritonavir (Kaletra) (400mg/100 mg twice a day for 10 days, orally, in two groups). Result: A total of 168 COVID- 19 confirmed patients underwent randomization; 83 were assigned to the intervention group and 85 were assigned to the control group. Median Time To Clinical Improvement (TTIC) for cases treated with low-dose IFN-β1a was shorter than that for cases treated with high-dose IFN-β1a (6 vs10 days). Due to differences between some baseline clinical factors between intervention and control group, we performed an adjusted analysis. The model failed to reach a significant difference between two groups. Conclusion: The use of high-dose IFN-β 1a did not improve TTCI in hospitalized patients with moderate to severe COVID-19. Also, it did not have any significant effect on mortality reduction compared with treating with low-dose IFN-β 1a.Trial registration: The trial was confirmed by the Ethics in Medical Research Committee of the Shahid Beheshti University of Medical Sciences. Signed informed consents were obtained from all the participants or their legally authorized representatives. This trial has been registered as ClinicalTrials.gov, NCT04521400.

scholarly journals Mucociliary transport in porcine trachea: differential effects of inhibiting chloride and bicarbonate secretion

2013 ◽  
Vol 304 (3) ◽  
pp. L184-L190 ◽  
Author(s):  
Jeffrey L. Cooper ◽  
Paul M. Quinton ◽  
Stephen T. Ballard
Keyword(s):  
Free Group ◽  
Ex Vivo ◽  
Treated Group ◽  
Control Group ◽  
Mucociliary Transport ◽  
Parallel Group ◽  
Significant Difference ◽  
Series Of Experiments ◽  
The Mean ◽  
And Control

This study was designed to assess the relative importance of Cl− and HCO3− secretion to mucociliary transport rate (MCT) in ex vivo porcine tracheas. MCT was measured in one group of tissues that was exposed to adventitial HCO3−-free solution while a parallel group was exposed to adventitial HCO3−-replete solution. After measurement of baseline MCT rates, acetylcholine (ACh) was added to stimulate submucosal gland mucous liquid secretion, and MCT rates were again measured. Before ACh addition, the mean MCT was higher in the HCO3−-free group (4.2 ± 0.9 mm/min) than in the HCO3−-replete group (2.3 ± 0.3 mm/min), but this difference was not statistically significant. ACh addition significantly increased MCT in both groups, but ACh-stimulated MCT was significantly lower in the HCO3−-free group (11.0 ± 1.5 mm/min) than in the HCO3−-replete group (17.0 ± 2.0 mm/min). A second series of experiments examined the effect on MCT of blocking Cl− secretion with 100 μM bumetanide. Before adding ACh, MCT in the bumetanide-treated group (1.0 ± 0.2 mm/min) was significantly lower than in the control group (3.8 ± 1.1 mm/min). ACh addition significantly increased MCT in both groups, but there was no significant difference between the bumetanide-treated group (21.4 ± 1.7 mm/min) and control group (19.5 ± 3.4 mm/min). These results indicate that ACh-stimulated MCT has greater dependence on HCO3− secretion, whereas the basal MCT rate has greater dependence on Cl− secretion.

Effects of Virgin Coconut Oil as Adjunct Therapy in the Treatment of Allergic Rhinitis

2016 ◽  
Vol 1 (1) ◽  
pp. 22
Author(s):  
Nazli Zainuddin ◽  
Nurul Azira Mohd Shah ◽  
Rosdan Salim
Keyword(s):  
Allergic Rhinitis ◽  
Side Effects ◽  
Coconut Oil ◽  
Test Group ◽  
Nasal Symptom ◽  
Control Group ◽  
Virgin Coconut Oil ◽  
Control Groups ◽  
Significant Difference ◽  
And Control

Introduction: The role of virgin coconut oil in the treatment of allergic rhinitis is controversial. Thus, the aim of the present study is to determine the effects of virgin coconut oil ingestion, in addition to standard medications, on allergic rhinitis. We also studied the side effects of consumption of virgin coconut oil. Methods: Fifty two subjects were equally divided into test and control groups. All subjects received a daily dose of 10mg of loratadine for 28 days. The test group was given 10ml of virgin coconut oil three times a day in addition to loratadine. The symptoms of allergic rhinitis were scored at the beginning and end of the study. Results:, the symptom score were divided into nasal and non-nasal symptom scores. Sneezing score showed a significant difference, however the score was more in control group than test group, indicating that improvement in symptom was more in control group. The rest of the nasal symptom and non-nasal symptom score showed no significant difference between test and control groups. Approximately 58% of the test subjects developed side effects from consumption of virgin coconut oil, mainly gastrointestinal side effects. Conclusion: In the present study, ingestion of virgin coconut oil does not improve the overall and individual symptoms of allergic rhinitis, furthermore it has side effects.

Sign in / Sign up

Export Citation Format

Share Document